Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K013005
    Manufacturer
    Date Cleared
    2002-03-08

    (183 days)

    Product Code
    Regulation Number
    882.4100
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    ACT 11 MP VENTRICULAR CATHETER

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The use of the ACT II MP Monitoring System by a qualified neurosurgeon is indicated when direct measurement of intracranial pressure in patients is required and when the patient may require CSF drainage in the course of their care or when data from a second parameter may be deemed useful in optimum patient management.

    Device Description

    The ICP monitor uses a bolt anchored in the skull. The bolt holds an air-column catheter with a flaccid bladder on the distal end. The proximal end of the catheter is attached to a pressure transducer placed in the distal end of a standard cable. The cable can be attached directly to any patient monitor. The ICP monitoring technology is based on Boyle's law. The bladder volume changes to accommodate PTV =P2V2 The pressure in the bladder, catheter and transducer thereby mirrors that of ICP. The air required to activate the bladder is introduced into the bladder when a piston on the proximal end of the catheter is joined to a cylinder on the transducer housing. The bladder air is replaced once per shift by removing and replacing the transducer housing on the piston.

    A probe guide is incorporated into the cap placed on the bolt at the factory and into the cap that accompanies the drainage catheter. The guides direct the path of a probe inserted through the cap/bolt. The guide tube does not enter the brain but stops just above the drill hole. Both caps provide a compression fitting that secures and seals the probe to the cap.

    The catheter is a single lumen catheter. A preloaded stylet is used for catheter insertion and placement. A luer connector is provided to connect the catheter to a standard CSF collection system.

    The bolt provides an access port through which a ventricular catheter can be introduced if drainage is needed. Should drainage of CSF be indicated, the top cap of the bolt is removed and the ACT II Ventricular Catheter is inserted into a ventricle. Once the catheter is in place, a preinstalled elastomeric sleeve and compression cap are moved down the catheter to the bolt. The cap compresses the sleeve against the bolt and catheter anchors the catheter in place.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the ACT II MP ICP Monitoring System, based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    CharacteristicAcceptance CriteriaReported Device Performance
    Mechanical IntegrityNo parts come loose and are left in the patient.Basic design assures no parts come loose. Interference rib design provides a secure fit. Compression fitting secures probe and provides effective seal.
    BiocompatibilityMaterials in contact with the body are biocompatible.Materials for ACT II MP ICP Monitoring System and ACT II MP Ventricular Catheter are biocompatible, based on testing from the predicate ACT II ICP Monitoring System and ACT II Ventricular Catheter.
    AccuracyMeets AAMI performance standards.ICP monitoring system meets AAMI standards for accuracy and performance.
    Ease of Use (Mounting)Catheter held in place by a compression device.Catheter is mounted in a bolt and held by a compression device, similar to the predicate probe introduction device.
    SetupNo preconditioning or calibration beyond transducer.No preconditioning or calibration beyond normal 2-second transducer zero. Transducer connects directly to patient monitor.
    Operating LifeBladder air replaced every shift.IFU requires bladder air replacement every shift; this is done by disconnecting/reconnecting the transducer.
    TroubleshootingTransducer function and patient monitor zero can be checked at any time.Transducer function and patient monitor zero can be checked at any time (unlike other in-situ systems).
    ICP MonitoringFaithfully follows ventricular pressure and waveform.Animal test data shows the device faithfully follows ventricular pressure and waveform.
    Bolt AnchoringBolt is securely anchored in the skull.Animal test data shows the bolt is securely anchored in the skull.
    Biocompatibility (Bolt)Met ISO 10993-1-1994 and FDA General Program Memorandum No. G95-1.Biocompatibility of the ACT II ICP Monitoring System related to the bolt was tested and met the specified standards.
    Probe GuideGuide tube does not enter the brain; directs path.The guide tube does not enter the brain, stopping above the dura. It directs the path of an inserted probe.

    2. Sample Size Used for the Test Set and Data Provenance

    The provided text does not specify a sample size for a test set or the data provenance (e.g., country of origin, retrospective/prospective) for a clinical study related to this specific modification (the MP version).

    The text mentions:

    • "Animal test data of the subject device vs. a ventricular catheter shows the device faithfully follows the ventricular pressure and waveform and that the bolt is securely anchored in the skull." This implies animal testing was conducted.
    • "Laboratory testing has shown that the ACT II MP ICP Monitoring System... are safe in the following areas: Mechanical integrity; Biocompatibility." This refers to laboratory tests, not human clinical trials.

    3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications

    This information is not provided in the document. The study described is primarily animal and laboratory testing, not a human clinical trial where expert-established ground truth would be relevant in the same way (e.g., for diagnostic accuracy).

    4. Adjudication Method for the Test Set

    This information is not provided. Given the nature of the described animal and laboratory testing, an adjudication method like 2+1 or 3+1 (typically used in human reader studies for diagnostic accuracy) would not be applicable.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    A multi-reader multi-case (MRMC) comparative effectiveness study was not mentioned or described in the provided text. The device is a medical monitoring system, not an AI diagnostic tool primarily aimed at improving human reader performance.

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    This is not applicable as the device described is a physical intracranial pressure monitoring system and associated components, not a software algorithm.

    7. Type of Ground Truth Used

    Based on the text, the ground truth for the performance evaluation comes from:

    • Physiological measurements in animal models (e.g., actual ventricular pressure and waveform).
    • Laboratory test results (e.g., mechanical integrity tests, biocompatibility tests against ISO standards).
    • Consensus standards (AAMI performance standards for accuracy).

    8. Sample Size for the Training Set

    This is not applicable. The device is a physical medical device, not an AI/ML algorithm that requires a training set.

    9. How the Ground Truth for the Training Set Was Established

    This is not applicable for the same reason as above (not an AI/ML algorithm).

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1